Literature DB >> 11254474

Autoregulation of glucose production in men with a glycerol load during rest and exercise.

J K Trimmer1, G A Casazza, M A Horning, G A Brooks.   

Abstract

Related to hepatic autoregulation we evaluated hypotheses that 1) glucose production would be altered as a result of a glycerol load, 2) decreased glucose recycling rate (Rr) would result from increased glycerol uptake, and 3) the absolute rate of gluconeogenesis (GNG) from glycerol would be positively correlated to glycerol rate of disappearance (R(d)) during a glycerol load. For these purposes, glucose and glycerol kinetics were determined in eight men during rest and during 90 min of leg cycle ergometry at 45 and 65% of peak O2 consumption (.VO2 (peak)). Trials were conducted after an overnight fast, with exercise commencing 12 h after the last meal. Subjects received a continuous infusion of [6,6-(2)H(2)]glucose, [1-(13)C]glucose, and [1,1,2,3,3-(2)H(5)]glycerol without (CON) or with an additional 1,000 mg (rest: 20 mg/min; exercise: 40 mg/min) of [2-(13)C]- or unlabeled glycerol added to the infusate (GLY). Infusion of glycerol dampened glucose Rr, calculated as the difference between [6,6-(2)H(2)]- and [1-(13)C]glucose rates of appearance (R(a)), at rest [0.35 +/- 0.12 (CON) vs. 0.12 +/- 0.10 mg. kg(-1). min(-1) (GLY), P < 0.05] and during exercise at both intensities [45%: 0.63 +/- 0.14 (CON) vs. 0.04 +/- 0.12 (GLY); 65%: 0.73 +/- 0.14 (CON) vs. 0.04 +/- 0.17 mg. kg(-1). min(-1) (GLY), P < 0.05]. Glucose R(a) and oxidation were not affected by glycerol infusion at rest or during exercise. Throughout rest and both exercise intensities, glycerol R(d) was greater in GLY vs. CON conditions (rest: 0.30 +/- 0.04 vs. 0.58 +/- 0.04; 45%: 0.57 +/- 0.07 vs. 1.19 +/- 0.04; 65%: 0.73 +/- 0.06 vs. 1.27 +/- 0.05 mg. kg(-1). min(-1), CON vs. GLY, respectively). Differences in glycerol R(d) (DeltaR(d)) between protocols equaled the unlabeled glycerol infusion rate and correlated with plasma glycerol concentration (r = 0.97). We conclude that infusion of a glycerol load during rest and exercise at 45 and 65% of .VO2(peak) 1) does not affect glucose R(a) or R(d), 2) blocks glucose Rr, 3) increases whole body glycerol R(d) in a dose-dependent manner, and 4) results in gluconeogenic rates from glycerol equivalent to CON glucose recycling rates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254474     DOI: 10.1152/ajpendo.2001.280.4.E657

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  6 in total

1.  Computational model of in vivo human energy metabolism during semistarvation and refeeding.

Authors:  Kevin D Hall
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01-31       Impact factor: 4.310

2.  Metabolic fate of a large amount of 13C-glycerol ingested during prolonged exercise.

Authors:  D Massicotte; A Scotto; F Péronnet; H M'Kaouar; M Milot; C Lavoie
Journal:  Eur J Appl Physiol       Date:  2005-12-21       Impact factor: 3.078

3.  Lactate and glucose interactions during rest and exercise in men: effect of exogenous lactate infusion.

Authors:  Benjamin F Miller; Jill A Fattor; Kevin A Jacobs; Michael A Horning; Franco Navazio; Michael I Lindinger; George A Brooks
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

4.  Predicting metabolic adaptation, body weight change, and energy intake in humans.

Authors:  Kevin D Hall
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

5.  Glycerol hyperhydration fails to improve endurance performance and thermoregulation in humans in a warm humid environment.

Authors:  Frank E Marino; Derek Kay; Jack Cannon
Journal:  Pflugers Arch       Date:  2003-04-15       Impact factor: 3.657

6.  Gluconeogenesis and hepatic glycogenolysis during exercise at the lactate threshold.

Authors:  Chi-An W Emhoff; Laurent A Messonnier; Michael A Horning; Jill A Fattor; Thomas J Carlson; George A Brooks
Journal:  J Appl Physiol (1985)       Date:  2012-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.